Net revenue climbed 69.7% year over year to RMB 1.92 billion (about US$285.9 million), the company's highest quarterly total since the second quarter of 2022. International markets drove the result, accounting for 86.5% of total net revenue following the July consolidation of a newly acquired Western European distribution business.
Third quarter 2026 net revenue reached RMB1.92 billion, up 69.7% year over year and 89.7% quarter over quarter, the highest level since the second quarter of 2022. International markets contributed 86.5% of total revenue following the July consolidation of RLX's newly acquired Western European distribution business.
The central target of $2.70 is the arithmetic mean of two verifiable, named analyst price targets: Citigroup at $2.50 (Neutral, March 2026) and UBS at $2.85 (Buy, August 2025). At a latest price near $1.40, reaching $2.70 would require roughly a 93% gain, a very large move by any standard.
RLX is the NYSE-listed American depositary share (ADS) of RLX Technology Inc., a China-based developer and manufacturer of e-vapor (vaping) products sold under its flagship RELX brand. The company was founded in 2018 and is headquartered in Shenzhen, China, with a business model built around branded products, in-house research and development, and an integrated offline distribution network.
Third quarter net revenues rose 69.7% year over year to RMB 1.92 billion (about US$285.9 million), the highest quarterly top line since the second quarter of 2022. Net income attributable to RLX Technology declined to RMB 160.7 million from RMB 203.2 million a year earlier, while diluted earnings per share (EPS) eased to RMB 0.123 from RMB 0.157.
ISPR dropped -10.53% to $1.36 from Monday's close of $1.52, with the decline recorded in the opening minutes of Tuesday's regular session rather than in premarket or after-hours trading. No verified news or fundamental catalyst found — no company release, filing or analyst action was identified ahead of the move; the drop is likely continued unwinding of the post-earnings rebound in a thinly traded micro-cap that has averaged a 3.55% daily swing over the past 70 sessions.
Shares dropped from Thursday's $8.32 close to $7.82 in the opening minutes of Friday's regular session, a -6.01% decline. The move reverses part of Thursday's +9.76% post-earnings surge, which came despite Q3 results released that morning missing consensus: EPS of $0.05 versus $0.06 expected, revenue below estimates, gross margin compressed, and year-end leverage guided up to about 2.5x.
The central target of $10.85 is the arithmetic mean of three verified analyst price targets — $10.00, $11.50, and $11.03 — which averages to $10.84. At a recent price of roughly $7.58, reaching $10.85 would require an advance of about 43%, a substantial move.
TPB is little changed today, slipping -0.19% from its previous close of $58.81 to $58.70 during regular market hours. No verified news or fundamental catalyst found. The drift is consistent with consolidation after a sharp post-earnings selloff, with Q3 results already absorbed in prior sessions.
ISPR slipped from a prior close of $1.67 to about $1.62, down -2.99%, during regular trading on November 10. No verified news or fundamental catalyst found today. The -2.99% dip is consistent with profit-taking after a roughly +24% five-session rally, matching the stock's typical ~3.5% daily move.
The central price target examined here is $4.90 , calculated as the arithmetic mean of the two current, verifiable analyst price targets on file ($3.30 and $6.50). With Ispire Technology Inc. (ISPR) trading near $1.67, reaching $4.90 would require a rise of roughly 193% — a very large move.
Ispire Technology reported a net loss of $0.11 per share for the first quarter of fiscal 2027, missing the consensus estimate of a $0.03 loss. Revenue came in at roughly $27.5 million, down 9.3% year over year but up 3.2% sequentially from the prior quarter.
The central $4.90 target is the arithmetic mean of the two verified analyst price targets currently in use, from BTIG and Roth MKM. Analyst targets span a wide range from $3.30 to $6.50, underscoring significant disagreement about the company's trajectory.
Total net sales rose 27.0% year over year to $151.1 million, driven by triple-digit growth in the Modern Oral nicotine pouch category. Net income fell 81.4% to $3.9 million, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) declined 41.3% to $18.4 million as sales and marketing investment climbed.
The central target of $115 is the arithmetic mean of five verified analyst price targets on Turning Point Brands, Inc. (TPB) . At the most recent close of $65.88, reaching $115 would require upside of roughly 75%, a very large move.
TPB shares slipped from a prior close of $65.88 to $64.70, a decline of -1.79%, during regular market hours on Monday. The company reported Q3 2026 results today, beating EPS ($0.41 vs. $0.35 est.) and revenue ($151.1M vs. $148.1M est.), but net income fell -81% and adjusted EBITDA dropped -41% year-over-year on heavy marketing investment, pressuring the stock.
Turning Point Brands shares dropped -8.91% to $60.01 from the prior close of $65.88, with the move occurring during regular market hours in the early session. The decline followed this morning's Q3 2026 earnings release: TPB beat EPS ($0.41 vs. $0.35) and revenue ($151.1M vs. $148.1M) estimates, but net income fell roughly 81% year over year as heavy marketing spend pressured profitability.
The central target of $220 is the arithmetic mean of the verified analyst price targets that sit above the current share price, reflecting a roughly 11% move from the latest close of $197.88. Across all valid targets, the overall mean is about $213, with a wide low-to-high range of roughly $175 to $240, underscoring meaningful disagreement among analysts.
PM is Philip Morris International Inc., one of the world's largest publicly traded tobacco companies, focused on markets outside the United States. The company was spun off from MO (Altria Group) in 2008 and is best known for the Marlboro cigarette brand, sold internationally.
Revenue reached $23.86 million for the third quarter ended September 30, 2026, up from $4.04 million in the year-ago period. Net loss narrowed sharply to $0.53 million , or $0.07 per share , versus a loss of $10.67 million, or $5.33 per share, a year earlier.